These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

365 related items for PubMed ID: 31682129

  • 1. Phase Behavior of Amorphous Solid Dispersions of Felodipine: Homogeneity and Drug-Polymer Interactions.
    Sarpal K, Delaney S, Zhang GGZ, Munson EJ.
    Mol Pharm; 2019 Dec 02; 16(12):4836-4851. PubMed ID: 31682129
    [Abstract] [Full Text] [Related]

  • 2. Amorphous Solid Dispersions of Felodipine and Nifedipine with Soluplus®: Drug-Polymer Miscibility and Intermolecular Interactions.
    Sarpal K, Munson EJ.
    J Pharm Sci; 2021 Apr 02; 110(4):1457-1469. PubMed ID: 33359813
    [Abstract] [Full Text] [Related]

  • 3. Hydrogen Bonding Interactions in Amorphous Indomethacin and Its Amorphous Solid Dispersions with Poly(vinylpyrrolidone) and Poly(vinylpyrrolidone-co-vinyl acetate) Studied Using (13)C Solid-State NMR.
    Yuan X, Xiang TX, Anderson BD, Munson EJ.
    Mol Pharm; 2015 Dec 07; 12(12):4518-28. PubMed ID: 26512737
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Role of the Strength of Drug-Polymer Interactions on the Molecular Mobility and Crystallization Inhibition in Ketoconazole Solid Dispersions.
    Mistry P, Mohapatra S, Gopinath T, Vogt FG, Suryanarayanan R.
    Mol Pharm; 2015 Sep 08; 12(9):3339-50. PubMed ID: 26070543
    [Abstract] [Full Text] [Related]

  • 18. Probing the effects of experimental conditions on the character of drug-polymer phase diagrams constructed using Flory-Huggins theory.
    Donnelly C, Tian Y, Potter C, Jones DS, Andrews GP.
    Pharm Res; 2015 Jan 08; 32(1):167-79. PubMed ID: 25074468
    [Abstract] [Full Text] [Related]

  • 19. Evaluate the ability of PVP to inhibit crystallization of amorphous solid dispersions by density functional theory and experimental verify.
    Wang B, Wang D, Zhao S, Huang X, Zhang J, Lv Y, Liu X, Lv G, Ma X.
    Eur J Pharm Sci; 2017 Jan 01; 96():45-52. PubMed ID: 27568852
    [Abstract] [Full Text] [Related]

  • 20. Ability of different polymers to inhibit the crystallization of amorphous felodipine in the presence of moisture.
    Konno H, Taylor LS.
    Pharm Res; 2008 Apr 01; 25(4):969-78. PubMed ID: 17520180
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.